GlobalData on MSN10 个月
Nyxoah’s nerve stimulation device meets endpoints in sleep apnoea study
Nyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in ...